Cargando…
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
Autores principales: | Sahraei, Zahra, Shabani, Minoosh, Shokouhi, Shervin, Saffaei, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156117/ https://www.ncbi.nlm.nih.gov/pubmed/32194152 http://dx.doi.org/10.1016/j.ijantimicag.2020.105945 |
Ejemplares similares
-
Evaluation of the prophylactic effect of hydroxychloroquine on people in close-contact with patients with COVID-19
por: Shabani, Minoosh, et al.
Publicado: (2021) -
Jellyfish Stings Rarely Induced Infectious Cellulitis: First Aid Remedies as Double-Edged Sword
por: Shabani, Minoosh, et al.
Publicado: (2019) -
Evaluation of vancomycin pharmacokinetics in patients with augmented renal clearances: A randomized clinical trial
por: Sahraei, Zahra, et al.
Publicado: (2022) -
Blood Glucose Control and Opportunities for Clinical Pharmacists in Infectious Diseases Ward
por: Shabani, Minoosh, et al.
Publicado: (2019) -
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
por: Quiros Roldan, Eugenia, et al.
Publicado: (2020)